Mary E Reid

Roswell Park Cancer Institute Corp

$2,296,661

Attributed

$4,610,722

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $861.9K · FY2006–25

$1M$750K$500K$250K$0

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,610,722 · 3

By mechanism

R01$4,547,467 · 2

R03$63,255 · 1

Top collaborators

Most similar at Roswell Park Cancer Institute Corp

Same institution · by research overlap

Saikrishna Yendamuri$2,302,224
Steven C Pruitt$8,877,290
Joseph Barbi$1,141,217
Richard J O'Connor$21,371,886
Mukund Seshadri$11,493,912

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsMalignant Neoplasm Of LungChemopreventionChemopreventive AgentLungTissuesOralCarcinogenesisTobacco-Associated CarcinogenCigarette SmokingHigh RiskRandomizedSamplingPreventSiteBiopsyCancer EtiologyMutationSquamous Cell CarcinomaPathway InteractionsProgramsAnti-CancerClinical TrialsCells